Total Payments
$9,354
2024 Payments
$2,640
Companies
24
Transactions
574
Medicare Patients
426
Medicare Billing
$57,224
Payment Breakdown by Category
Food & Beverage$9,205 (98.4%)
Education$148.65 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,205 | 571 | 98.4% |
| Education | $148.65 | 3 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,061 | 79 | $0 (2024) |
| Lundbeck LLC | $1,004 | 54 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $964.02 | 50 | $0 (2024) |
| ABBVIE INC. | $949.35 | 66 | $0 (2024) |
| Alkermes, Inc. | $850.52 | 47 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $698.20 | 48 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $655.59 | 41 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $588.07 | 37 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $545.58 | 32 | $0 (2024) |
| Axsome Therapeutics, Inc. | $373.07 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,640 | 171 | ABBVIE INC. ($346.51) |
| 2023 | $3,346 | 204 | Lundbeck LLC ($369.03) |
| 2022 | $2,224 | 128 | Janssen Pharmaceuticals, Inc ($408.32) |
| 2021 | $1,144 | 71 | Otsuka America Pharmaceutical, Inc. ($247.63) |
All Payment Transactions
574 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.94 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $8.95 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/03/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: CNS | ||||||
| 11/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $19.34 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.11 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: CNS | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $22.90 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/05/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $7.67 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 102 | 277 | $44,530 | $17,559 |
| 2022 | 5 | 206 | 413 | $56,030 | $22,392 |
| 2021 | 4 | 118 | 279 | $35,605 | $17,274 |
Total Patients
426
Total Services
969
Medicare Billing
$57,224
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 184 | $27,600 | $9,836 | 35.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 79 | $13,430 | $6,054 | 45.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 14 | 14 | $3,500 | $1,669 | 47.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 175 | $26,250 | $9,507 | 36.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 107 | $18,190 | $7,530 | 41.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 33 | 33 | $8,250 | $3,740 | 45.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 27 | 34 | $2,380 | $1,437 | 60.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 35 | 64 | $960.00 | $178.02 | 18.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 136 | $23,120 | $11,374 | 49.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 31 | 31 | $7,750 | $3,728 | 48.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $3,250 | $1,818 | 55.9% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 36 | 99 | $1,485 | $354.42 | 23.9% |
About Abraham Kimeli, NP
Abraham Kimeli, NP is a Family healthcare provider based in Saginaw, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2018. The National Provider Identifier (NPI) number assigned to this provider is 1215404413.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Abraham Kimeli, NP has received a total of $9,354 in payments from pharmaceutical and medical device companies, with $2,640 received in 2024. These payments were reported across 574 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($9,205).
As a Medicare-enrolled provider, Kimeli has provided services to 426 Medicare beneficiaries, totaling 969 services with total Medicare billing of $57,224. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Psychiatric/Mental Health
- Location Saginaw, MI
- Active Since 10/26/2018
- Last Updated 03/02/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1215404413
Products in Payments
- REXULTI (Drug) $1,339
- VRAYLAR (Drug) $949.35
- ARISTADA (Drug) $830.55
- SPRAVATO (Drug) $589.59
- INGREZZA (Drug) $588.07
- ABILIFY MAINTENA (Drug) $574.90
- TRINTELLIX (Drug) $545.58
- QELBREE (Drug) $542.65
- CAPLYTA (Drug) $467.01
- INVEGA SUSTENNA (Drug) $374.43
- Auvelity (Drug) $373.07
- AUSTEDO (Drug) $280.14
- JORNAY PM (Drug) $272.63
- QUVIVIQ (Drug) $175.14
- Azstarys (Drug) $158.24
- Qelbree (Drug) $155.55
- PERSERIS (Drug) $137.26
- Austedo XR (Drug) $129.49
- AZSTARYS (Drug) $104.14
- BRINTELLIX (Drug) $100.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Saginaw
Gladys Kimeli, Np, NP
Family — Payments: $13,154
Family $13,154
Helen Decorte, N.p, N.P
Family — Payments: $9,441
Family $9,441
Mrs. Melissa Duron, Fnp, FNP
Family — Payments: $5,083
Family $5,083
Amber Fritzler
Family — Payments: $4,561
Family $4,561
Melissa Duchene, Fnp-Bc, FNP-BC
Family — Payments: $4,020
Family $4,020
Aubree Dalton, Fnp-Bc, FNP-BC
Family — Payments: $3,734
Family $3,734